423 related articles for article (PubMed ID: 28449098)
21. Host-pathogen interactions of nontypeable Haemophilus influenzae: from commensal to pathogen.
Duell BL; Su YC; Riesbeck K
FEBS Lett; 2016 Nov; 590(21):3840-3853. PubMed ID: 27508518
[TBL] [Abstract][Full Text] [Related]
22. Haemophilus influenzae oral vaccination for preventing acute exacerbations of chronic bronchitis and chronic obstructive pulmonary disease.
Teo E; House H; Lockhart K; Purchuri SN; Pushparajah J; Cripps AW; van Driel ML
Cochrane Database Syst Rev; 2014 Sep; (9):CD010010. PubMed ID: 25201571
[TBL] [Abstract][Full Text] [Related]
23. Discovery and Contribution of Nontypeable Haemophilus influenzae NTHI1441 to Human Respiratory Epithelial Cell Invasion.
Ahearn CP; Kirkham C; Chaves LD; Kong Y; Pettigrew MM; Murphy TF
Infect Immun; 2019 Nov; 87(11):. PubMed ID: 31427451
[TBL] [Abstract][Full Text] [Related]
24. Haemophilus influenzae oral vaccination for preventing acute exacerbations of chronic bronchitis and chronic obstructive pulmonary disease.
Teo E; Lockhart K; Purchuri SN; Pushparajah J; Cripps AW; van Driel ML
Cochrane Database Syst Rev; 2017 Jun; 6(6):CD010010. PubMed ID: 28626902
[TBL] [Abstract][Full Text] [Related]
25. Immunoglobulin A Protease Variants Facilitate Intracellular Survival in Epithelial Cells By Nontypeable Haemophilus influenzae That Persist in the Human Respiratory Tract in Chronic Obstructive Pulmonary Disease.
Murphy TF; Kirkham C; Gallo MC; Yang Y; Wilding GE; Pettigrew MM
J Infect Dis; 2017 Dec; 216(10):1295-1302. PubMed ID: 28968876
[TBL] [Abstract][Full Text] [Related]
26. The host immune response contributes to Haemophilus influenzae virulence.
Geelen TH; Gaajetaan GR; Wouters EF; Rohde GG; Franssen FM; Grauls GE; Stobberingh EE; Bruggeman CA; Stassen FR
Respir Med; 2014 Jan; 108(1):144-52. PubMed ID: 24011804
[TBL] [Abstract][Full Text] [Related]
27. Resveratrol therapeutics combines both antimicrobial and immunomodulatory properties against respiratory infection by nontypeable Haemophilus influenzae.
Euba B; López-López N; Rodríguez-Arce I; Fernández-Calvet A; Barberán M; Caturla N; Martí S; Díez-Martínez R; Garmendia J
Sci Rep; 2017 Oct; 7(1):12860. PubMed ID: 29038519
[TBL] [Abstract][Full Text] [Related]
28. Detection of Cell-Dissociated Non-Typeable
Thulborn SJ; Ceroni A; Haldar K; Mistry V; Cane JL; Brightling CE; Barer MR; Bafadhel M
Int J Chron Obstruct Pulmon Dis; 2020; 15():1357-1365. PubMed ID: 32606645
[TBL] [Abstract][Full Text] [Related]
29. Whole-genome analyses reveal gene content differences between nontypeable
Kc R; Leong KWC; Harkness NM; Lachowicz J; Gautam SS; Cooley LA; McEwan B; Petrovski S; Karupiah G; O'Toole RF
Microb Genom; 2020 Aug; 6(8):. PubMed ID: 32706329
[TBL] [Abstract][Full Text] [Related]
30. Role of nontypeable Haemophilus influenzae in otitis media and chronic obstructive pulmonary disease.
Thanavala Y; Lugade AA
Adv Otorhinolaryngol; 2011; 72():170-5. PubMed ID: 21865721
[TBL] [Abstract][Full Text] [Related]
31. Haemophilus influenzae: recent advances in the understanding of molecular pathogenesis and polymicrobial infections.
Jalalvand F; Riesbeck K
Curr Opin Infect Dis; 2014 Jun; 27(3):268-74. PubMed ID: 24699388
[TBL] [Abstract][Full Text] [Related]
32. Non-typeable Haemophilus influenzae invasion and persistence in the human respiratory tract.
Clementi CF; Murphy TF
Front Cell Infect Microbiol; 2011; 1():1. PubMed ID: 22919570
[TBL] [Abstract][Full Text] [Related]
33. Infectious exacerbations of chronic obstructive pulmonary disease associated with respiratory viruses and non-typeable Haemophilus influenzae.
Bandi V; Jakubowycz M; Kinyon C; Mason EO; Atmar RL; Greenberg SB; Murphy TF
FEMS Immunol Med Microbiol; 2003 Jun; 37(1):69-75. PubMed ID: 12770762
[TBL] [Abstract][Full Text] [Related]
34. Dectin-1 is expressed in human lung and mediates the proinflammatory immune response to nontypeable Haemophilus influenzae.
Heyl KA; Klassert TE; Heinrich A; Müller MM; Klaile E; Dienemann H; Grünewald C; Bals R; Singer BB; Slevogt H
mBio; 2014 Aug; 5(5):e01492-14. PubMed ID: 25161190
[TBL] [Abstract][Full Text] [Related]
35. Non-typeable Haemophilus influenzae, an under-recognised pathogen.
Van Eldere J; Slack MP; Ladhani S; Cripps AW
Lancet Infect Dis; 2014 Dec; 14(12):1281-92. PubMed ID: 25012226
[TBL] [Abstract][Full Text] [Related]
36. Non-typeable Haemophilus influenzae protein vaccine in adults with COPD: A phase 2 clinical trial.
Wilkinson TMA; Schembri S; Brightling C; Bakerly ND; Lewis K; MacNee W; Rombo L; Hedner J; Allen M; Walker PP; De Ryck I; Tasciotti A; Casula D; Moris P; Testa M; Arora AK
Vaccine; 2019 Sep; 37(41):6102-6111. PubMed ID: 31447126
[TBL] [Abstract][Full Text] [Related]
37. EF-Tu From Non-typeable
Thofte O; Su YC; Brant M; Littorin N; Duell BL; Alvarado V; Jalalvand F; Riesbeck K
Front Immunol; 2018; 9():2910. PubMed ID: 30619274
[TBL] [Abstract][Full Text] [Related]
38. Combined exposure to cigarette smoke and nontypeable Haemophilus influenzae drives development of a COPD phenotype in mice.
Ganesan S; Comstock AT; Kinker B; Mancuso P; Beck JM; Sajjan US
Respir Res; 2014 Feb; 15(1):11. PubMed ID: 24495712
[TBL] [Abstract][Full Text] [Related]
39. Antibody Binding and Complement-Mediated Killing of Invasive Haemophilus influenzae Isolates from Spain, Portugal, and the Netherlands.
Dudukina E; de Smit L; Verhagen GJA; van de Ende A; Marimón JM; Bajanca-Lavado P; Ardanuy C; Marti S; de Jonge MI; Langereis JD
Infect Immun; 2020 Sep; 88(10):. PubMed ID: 32719154
[No Abstract] [Full Text] [Related]
40. Relationship between azithromycin susceptibility and administration efficacy for nontypeable Haemophilus influenzae respiratory infection.
Euba B; Moleres J; Viadas C; Barberán M; Caballero L; Grilló MJ; Bengoechea JA; de-Torres JP; Liñares J; Leiva J; Garmendia J
Antimicrob Agents Chemother; 2015 May; 59(5):2700-12. PubMed ID: 25712355
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
